GeneMind Biosciences Secures RMB 400 Million in Series C Financing to Expand Gene Testing
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
South Korea-based molecular diagnostics firm Novomics Co. has announced a strategic partnership with China-based Hubei...
China-based genomics leader BGI Genomics Co., Ltd (SHE: 300676) has entered into a memorandum of...
This week, leading pharmaceutical companies AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), AstraZeneca (AZ; NASDAQ: AZN),...
Helio Genomics has announced that its ‘sister company’ Laboratory for Advanced Medicine & Health Group...
US-based AbbVie Inc., (NYSE: ABBV), the company behind the first-in-class Bruton’s tyrosine kinase (BTK) inhibitor...
Azenta Life Sciences (NASDAQ: AZTA) has entered into a global partnership with China-based Vazyme Biotech...
Suzhou Basecare Medical Co., Ltd (HKG: 2170), a China-based in vitro fertilization (IVF) specialist, has...
Shanghai-based Sequanta Technologies, a leading multi-omics research and clinical service provider, has announced a strategic...
Willingmed, a Beijing-based company specializing in molecular biology for clinical infection precision diagnosis, has reportedly...
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has struck a partnership with Shanghai...
Sino-US biopharma AnHeart Therapeutics and US precision oncology firm Guardant Health Inc. (NASDAQ: GH) have...
China-based gene testing service providers Tongshu Gene and LC Gene Diagnostics (Hangzhou) Co., Ltd. have...
Beijing Tsingke Biotech Co., Ltd. a gene synthesis company based in Beijing, reportedly raised RMB...
Salus Biomed, a sequencing and spatial omics platform provider based in Guangdong, has reportedly raised...
BGI Genomics Co., Ltd, a leading Chinese gene sequencing firm, has reportedly been added to...
China’s genomics giant BGI has revealed a landmark study using its proprietary Stereo-seq sequencing technology...
US-based Illumina (NASDAQ: ILMN) inaugurated its first manufacturing base in China on August 25, marking...
US-based Illumina (NASDAQ: ILMN) inaugurated its first manufacturing base in China on August 25, marking...
China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) has partnered with Genolmmune Therapeutics Biotechnology Co.,...